Skip to main content
. 2018 Dec 4;2018(12):CD011902. doi: 10.1002/14651858.CD011902.pub2

Lorentzen 1999a.

Study characteristics
Patient sampling Study design: case series
Data collection: prospective
Period of data collection: 1994‐1997
Country: Denmark
Patient characteristics and setting Inclusion criteria: patients with lesions suspicious for CMM referred to outpatients clinic; only excised included
Setting: NR
Prior testing: clinical suspicion of malignancy without dermatoscopic suspicion
Setting for prior testing: NR
Exclusion criteria: poor‐quality index test image (considered under flow/timing)
Sample size (participants): number eligible: 242; number included: 232
Sample size (lesions): number eligible: 242; number included: 232*
Participant characteristics: none reported
Lesion characteristics: none reported
*NB not all cases were assessed by all observers; 2x2 are based on presented sensitivity and specificity estimates for full dataset of lesions; "the dermatoscopy experts assessed almost all cases (98 ± 100%), whereas the non‐expert group completed fewer assessments, from 76%‐98%
Index tests VI: no algorithm
Method of diagnosis: clinical photographs
Prior test data: no further information used; no option to change clinical diagnosis after viewing dermoscopic image
Other test data: dermoscopic images presented to observer subsequent to diagnosis using clinical images alone; clinical images presented before dermoscopic images
Diagnostic threshold: NR; clinical diagnosis
Diagnosis based on: average; n = 9
Observer qualifications: dermatologist
Experience in practice: high; moderate; mixed (average reported); 4 'experienced dermatologists' (4‐5 years' daily experience) & 5 'non‐expert dermatology residents' (1‐2 years' interest and formal training in dermatoscopy)
Experience with index test: high; moderate; mixed
Dermoscopy: no algorithm
Method of diagnosis: dermoscopic images
Prior test data: clinical image presented first
Diagnostic threshold: clinical diagnosis; "observers were familiar with both the ABCD‐rule of dermatoscopy proposed by Stolz et al. (Stolz 1994b) and Kenet et al's risk‐stratifying algorithm of pigment network features of dermatoscopy (Kenet 1994). The observers were not constrained by either of the rules. The ABCD scores were not used to obtain the diagnoses. Rather a pattern recognition process was intended."
Dermoscopy training: described as "formal training"
Training format: non experts had undergone prior training in dermoscopy (not documented)
Target condition and reference standard(s) Reference standard: histological diagnosis alone
Details: a co‐author from Dept of Pathology "re‐evaluated all cases to confirm the pathology diagnosis, which was used as the gold standard in this study."
Disease‐positive: 65; disease‐negative: 167
Target condition (final diagnoses)
 Melanoma (invasive): 49 'malignant melanoma'
 BCC: 16
Sebhorrheic keratosis: 12; benign naevus: 137 (pigmented naevi = 116; blue naevi = 16; atypical naevi = 5); other: 18 (SN, BD, sarcoid, naevus spilus, hemangioma, and others)
Flow and timing Excluded participants: 10 cases were "considered unfit for evaluation" due to poor‐quality image
Reference interval: "biopsy specimens...were obtained after the clinical and dermatoscopic photographs had been performed"
Comparative Blinding between tests: Each observer first recorded the clinical diagnosis and then the dermatoscopic diagnosis on an entry form.
Time interval between index test(s): same day; at time of face‐to‐face consultation
Notes
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Was a case‐control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
Are the included patients and chosen study setting appropriate? No    
Did the study avoid including participants with multiple lesions? Unclear    
    Unclear High
DOMAIN 2: Index Test Visual inspection ‐ image‐based
Were the index test results interpreted without knowledge of the results of the reference standard? Yes    
If a threshold was used, was it pre‐specified? Unclear    
For studies reporting the accuracy of multiple diagnostic thresholds, was each threshold or algorithm interpreted without knowledge of the results of the others?      
Was the test applied and interpreted in a clinically applicable manner? No    
Were thresholds or criteria for diagnosis reported in sufficient detail to allow replication? No    
Was the test interpretation carried out by an experienced examiner? Yes    
    Unclear High
DOMAIN 2: Index Test Dermoscopy ‐ image‐based
Were the index test results interpreted without knowledge of the results of the reference standard? Yes    
If a threshold was used, was it pre‐specified? Yes    
For studies reporting the accuracy of multiple diagnostic thresholds, was each threshold or algorithm interpreted without knowledge of the results of the others?      
Was the test applied and interpreted in a clinically applicable manner? No    
Were thresholds or criteria for diagnosis reported in sufficient detail to allow replication? Yes    
Was the test interpretation carried out by an experienced examiner? Yes    
    Low High
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear    
Expert opinion (with no histological confirmation) was not used as a reference standard Yes    
Was histology interpretation carried out by an experienced histopathologist or by a dermatopathologist? Unclear    
    Low Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Yes    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? No    
If the reference standard includes clinical follow‐up of borderline/benign appearing lesions, was there a minimum follow‐up following application of index test(s) of at least: 3 months for melanoma or cSCC or 6 months for BCC?      
If more than one algorithm was evaluated for the same test, was the interval between application of the different algorithms 1 month or less?      
    High  
DOMAIN 5: Comparative
Was each index test result interpreted without knowledge of the results of other index tests or testing strategies? No    
Was the interval between application of the index tests less than one month? Yes    
Were all tests applied and interpreted in a clinically applicable manner? No    
    Low High